| Name: | REVITALID PHARMACEUTICAL CORP. |
| Jurisdiction: | Kentucky |
| Profit or Non-Profit: | Profit |
| Legal type: | Foreign Corporation |
| Status: | Inactive |
| Standing: | Bad |
| File Date: | 08 Feb 2019 (6 years ago) |
| Organization Date: | 14 Dec 2001 (23 years ago) |
| Authority Date: | 08 Feb 2019 (6 years ago) |
| Last Annual Report: | 09 Jun 2023 (2 years ago) |
| Organization Number: | 1047916 |
| Principal Office: | 400 Crossing Boulevard, Bridgewater, NJ 08807 |
| Place of Formation: | DELAWARE |
| Name | Role |
|---|---|
| Brian Markison | CEO |
| Name | Role |
|---|---|
| Andrew Einhorn | CFO |
| Andrew Einhorn | CFO |
| Name | Role |
|---|---|
| Christopher Klein | Secretary |
| Name | Role |
|---|---|
| Brian Markison | Director |
| Carlos Sielecki | Director |
| Daniel Sielecki | Director |
| Sriram Venkataraman | Director |
| David Burgstahler | Director |
| Juan Vergez | Director |
| Name | Role |
|---|---|
| Ryan Pomerantz | Authorized Rep |
| Name | Role |
|---|---|
| KY SECRETARY OF STATE | Registered Agent |
| Name | Action |
|---|---|
| Osmotica Pharmaceutical Corporation | Old Name |
| Name | File Date |
|---|---|
| Revocation of Certificate of Authority | 2024-10-12 |
| Annual Report | 2023-06-09 |
| Amended Cert of Authority | 2023-05-25 |
| Annual Report | 2022-05-05 |
| Annual Report | 2021-06-22 |
| Annual Report | 2020-06-10 |
Date of last update: 13 Jan 2025
Sources: Kentucky Secretary of State
